期刊文献+

消化系统肿瘤肝转移的治疗策略 被引量:7

Therapeutic strategy of liver metastasis from malignant digestive system tumors
原文传递
导出
摘要 转移是消化系统恶性肿瘤发展的终末阶段,而肝脏是其血源性转移最好发的部位.转移性肝癌的治疗主要有手术治疗、全身化疗、RFA、门静脉栓塞术、肝动脉导管栓塞术等不同手段.消化系统肿瘤肝转移的治疗仍处于探索阶段,不同治疗方法对不同瘤种的治疗效果不尽相同,临床工作者需要以多学科团队诊断与治疗为基础,围绕患者的疾病特点,制订系统化的综合治疗方案.但是随着临床经验的积累、新型有效化疗药物的出现以及肝转移灶手术适应证的拓展和大样本循证医学证据的涌现,消化系统肿瘤肝转移的治疗必将朝着一个越来越规范和有效的方向发展. Metastatic cancer is often occurred in advanced digestive system tumors and the most involved organ is liver.Multiple therapeutic managements and strategies such as surgery,systemic chemotherapy,radiofrequency ablation,portal vein embolization and transarterial chemoembolization are used in the treatment of liver metastasis.However,the treatment of advanced digestive system tumors liver metastasis is still challenging,different therapeutic methods show different results for different tumors,comprehensive treatment should be used based on features of patients and muliidisciplinary cooperation.With the accumulation of clinical experiences,the emergence of novel chemotherapeutics,wider indications of surgical resection in treating liver metastases and accumulated evidence from randomized controlled trials,the therapeutic management of metastatic hepatic cancer should be standardized and more effective in the future.
出处 《中华消化外科杂志》 CAS CSCD 北大核心 2016年第2期113-116,共4页 Chinese Journal of Digestive Surgery
基金 首都医学发展科研基金(TG2015002)
关键词 消化道肿瘤 肝转移癌 治疗学 Digestive system neoplasms Liver metastases Therapeutics
  • 相关文献

参考文献1

二级参考文献30

  • 1Bartlett DL, Fong Y, Fortner JG, Brennan MF, Blumgart LH. Long-term results after resection for gallbladder cancer. Im- plications for staging and management. Ann Surg 1996; 224: 639-646.
  • 2Benoist S, Panis Y, Fagniez PL. Long-term results after cura- tive resection for carcinoma of the gallbladder. French Uni- versity Association for Surgical Research. Am J Surg 1998; 175:118-122.
  • 3Fong Y, Jarnagin W, Blumgart LH. Gallbladder cancer: com- parison of patients presenting initially for definitive opera- tion with those presenting after prior noncurative interven- tion. Ann Surg 2000; 232:557-569.
  • 4Behari A, Sil-ora SS, Wagholikar GD, Kumar A, Saxena R, Kapoor VK. Longterm survival after extended resections in patients with gallbladder cancer. J Am Coll Surg 2003; 196: 82-88.
  • 5Ito H, Ito K, D'Angelica M, Gonen M, Klimstra D, Allen P, DeMatteo RP, Fong Y, Blumgart LH, Jarnagin WR. Accu- rate staging for gallbladder cancer: implications for surgical therapy and pathological assessment. Ann Surg 2011; 254: 320-325.
  • 6Shirai Y, Yoshida K, Tsukada K, Ohtani T, Muto T. Identifi- cation of the regional lymphatic system of the gallbladder by vital staining. Br J Surg 1992; 79:659-662.
  • 7Chijiiwa K, Tanaka M. Carcinoma of the gallbladder: an ap- praisal of surgical resection. Surgery 1994; 115:751-756.
  • 8Shimada H, Endo I, Togo S, Nakano A, Izumi T, Nakaga- wara G. The role of lymph node dissection in the treatment of gallbladder carcinoma. Cancer 1997; 79:892-899.
  • 9Wang JD, Liu YB, Quan ZW, Li SG, Wang XF, Shen J. Role of regional lymphadenectomy in different stage of gallbladder carcinoma. Hepatogastroenterology 2009; 56:593-596.
  • 10Sakata J, Shirai Y, Wakai T, Ajioka Y, Hatakeyama K. Num- ber of positive lymph nodes independently determines the prognosis after resection in patients with gallbladder carci- noma. Ann Surg Onco12010; 17:1831-1840.

共引文献36

同被引文献40

引证文献7

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部